Evidence map›Paper›PMID 24971581›Full record

ArticleGut microbes

Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis.

Delphine Payros, Thomas Secher, Michèle Boury, Camille Brehin, Sandrine Ménard, Christel Salvador-Cartier, Gabriel Cuevas-Ramos, Claude Watrin, Ingrid Marcq, Jean-Philippe Nougayrède and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. The synthesis of the novelFrontiers in microbiology · 2024
    Review
  8. Does month of birth influence colorectal cancer prognosis?Langenbeck's archives of surgery · 2023
    Observational
  9. Article
  10. Article
  11. Which bacterial toxins are worthy of validation as markers in colorectal cancer screening? A critical review.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Toxins · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 14 institutions in 3 countries.

Delphine PayrosINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France; Neuro-gastroenterologie & Nutrition; UMR Toxalim INRA/ENVT 1331; Toulouse, France.
Thomas SecherINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France.
Michèle BouryINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France.
Camille BrehinINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France; CHU Toulouse; Hôpital Purpan; Service de bactériologie-Hygiène; Toulouse, France.
Sandrine MénardNeuro-gastroenterologie & Nutrition; UMR Toxalim INRA/ENVT 1331; Toulouse, France.
Christel Salvador-CartierNeuro-gastroenterologie & Nutrition; UMR Toxalim INRA/ENVT 1331; Toulouse, France.
Gabriel Cuevas-RamosINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France.
Claude WatrinINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France.
Ingrid MarcqUniversité de Picardie Jules Verne; EA 4666 UFR de médecine d'Amiens, France.
Jean-Philippe NougayrèdeINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France.
Damien DuboisINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France; CHU Toulouse; Hôpital Purpan; Service de bactériologie-Hygiène; Toulouse, France.
Antoine BeduCHU Limoge; Service de Pédiatrie; Limoges, France.
Fabien GarnierUniversité de Limoges UMR-S1092; Limoges, France; Inserm U1092; Limoges, France.
Olivier ClermontInserm UMR-S 722; Univ Paris Diderot; PRES Sorbonne Cité; Paris, France.
Erick DenamurInserm UMR-S 722; Univ Paris Diderot; PRES Sorbonne Cité; Paris, France.
Pascale PlaisanciéINRA USC 1235; Inserm U1060; CarMeN laboratory; Villeurbanne, France.
Vassilia TheodorouNeuro-gastroenterologie & Nutrition; UMR Toxalim INRA/ENVT 1331; Toulouse, France.
Jean FioramontiNeuro-gastroenterologie & Nutrition; UMR Toxalim INRA/ENVT 1331; Toulouse, France.
Maïwenn OlierINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France; Neuro-gastroenterologie & Nutrition; UMR Toxalim INRA/ENVT 1331; Toulouse, France.
Eric OswaldINRA; USC 1360; Toulouse, France; Inserm; UMR1043; Toulouse, France; CNRS; UMR5282; Toulouse, France; Université de Toulouse; UPS; Toulouse, France; CHU Toulouse; Hôpital Purpan; Service de bactériologie-Hygiène; Toulouse, France.
Inserm · FRUniversité Toulouse III - Paul Sabatier · FRCentre National de la Recherche Scientifique · FRNutrition & Santé (Spain) · ESBipar · FRCentre Hospitalier Universitaire de Limoges · FRÉcole Nationale Vétérinaire de Toulouse · FRHôpital Purpan · FRToxalim Research Centre in Food Toxicology · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Limoges · FRUniversité de Picardie Jules Verne · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neonatal gut is rapidly colonized by a newly dominant group of commensal Escherichia coli strains among which a large proportion produces a genotoxin called colibactin. In order to analyze the short- and long-term effects resulting from such evolution, we developed a rat model mimicking the natural transmission of E. coli from mothers to neonates. Genotoxic and non-genotoxic E. coli strains were equally transmitted to the offspring and stably colonized the gut across generations. DNA damage was only detected in neonates colonized with genotoxic E. coli strains. Signs of genotoxic stress such as anaphase bridges, higher occurrence of crypt fission and accelerated renewal of the mature epithelium were detected at adulthood. In addition, we observed alterations of secretory cell populations and gut epithelial barrier. Our findings illustrate how critical is the genotype of E. coli strains acquired at birth for gut homeostasis at adulthood.

Indexed as

AnimalsDNA DamageEscherichia coliFemaleGastrointestinal TractHumansInfant, NewbornMaleModels, AnimalPeptidesPolyketidesPregnancyRats, WistarcolibactinPeptidesPolyketidescolibactinepithelial differentiationepithelial proliferationEscherichia coligenotoxicitygutintestinal barrierneonate

Identifiers

PMID24971581
PMCPMC4153768
OpenAlexW1989207761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.